About Amegh Pharma
Amegh Pharma is a company based in Mumbai (India) founded in 2007. It operates as a B2B. Amegh Pharma offers products and services including Pharmaceutical Formulations, Pharmaceutical APIs, Nutraceuticals and Herbals, and Surgicals. Amegh Pharma operates in a competitive market with competitors including AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
- Headquarter Mumbai, India
- SectorsHealthcare
- Email••••••••
- Website amegh.com
- Legal Name Amegh Pharma Private Limited
- Date of Incorporation 27 Jul, 2007
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹13.09 Cr
FY 2025 · -29% YoY
- Net Profit₹30.5 Lakh
FY 2025 · 2% margin
- EBITDA₹1.02 Cr
FY 2025 · 8% margin
Associated legal entities of Amegh Pharma
Amegh Pharma operates through Amegh Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amegh Pharma Private Limited CIN U24239MH2007PTC172642 | Active | 27 Jul 2007 | Mumbai, Maharashtra | ₹13.1 Cr | – | 2 | View details |
Products & Services of Amegh Pharma
Amegh Pharma offers a comprehensive portfolio of products and services, including Pharmaceutical Formulations, Pharmaceutical APIs, Nutraceuticals and Herbals, and Surgicals.
Manufactured medicines for therapeutic use in various treatments.
Raw materials essential for drug production and formulation.
Health products derived from natural sources for wellness.
Instruments and devices used in surgical procedures.
Board of directors of Amegh Pharma Private Limited (Amegh Pharma)
Amegh Pharma Private Limited is the primary company behind Amegh Pharma. The board of Amegh Pharma Private Limited currently have 2 directors; the longest-serving is Payal Mohan, appointed in 2007.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Payal Mohan DIN 01572350 | Director | 27 Jul 2007 | 19 yrs 2 mo | Amegh Pharma Private Limited |
| Vipul Mohan DIN 00270478 | Director | 27 Jul 2007 | 19 yrs 2 mo | Amegh Pharma Private Limited |
Financials of Amegh Pharma
Figures of Amegh Pharma Private Limited, the primary company behind Amegh Pharma, for FY 2025. Revenue was ₹13.09 Cr (-29% year on year). Net profit was ₹30.5 Lakh (2% margin). EBITDA was ₹1.02 Cr (8% margin). Revenue has grown at a compounded annual rate of -14% over three years and +5% over five years.
- ₹13.09 CrRevenue · FY 2025 · -29% YoY
- ₹30.5 LakhNet profit · 2% margin
- ₹1.02 CrEBITDA · 8% margin
- ₹50 LakhPaid-up capital
- -14%Revenue CAGR, 3 years
- +5%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Amegh Pharma Private Limited are on its company page.
Detailed financial statements for Amegh Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Amegh Pharma
Amegh Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmerisourceBergen, Entero Healthcare, Keimed, Sandor Medicaids and Mahaveer Medi Sales, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| amerisourcebergen.com | 1985 | Chesterbrook, United States | – | 46,000 | Pharmaceutical distribution and supply chain services are provided globally. | |
| enterohealthcare.com | 2018 | Mumbai, India | $59.67M | 817 | India's leading healthcare products distribution platform | |
| keimed.com | 2000 | Hyderabad, India | $16.62M | 588 | Temperature-sensitive medicines are distributed via cold chain logistics by Keimed. | |
| sandor.co.in | 1995 | Hyderabad, India | $11.53M | 161 | Provider of medical equipment, devices, and drugs distribution services | |
| mahaveermedi.com | 2016 | Bengaluru, India | – | 588 | Serves as a distributor of a wide range of pharmaceutical drugs. | |
| dipnapharmachem.com | 2011 | Ahmedabad, India | – | – | Distributor of pharmaceutical raw materials |
Detailed competitors of Amegh Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Amegh Pharma
10 companies that operate in the same segment as Amegh Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 215.5 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Amegh Pharma
Amegh Pharma was founded in 2007.
Amegh Pharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
The primary company behind Amegh Pharma, Amegh Pharma Private Limited, reported revenue of ₹13.09 Cr for FY 2025, down 29% year on year.
Amegh Pharma , Founded In 2007 In Mumbai, India, Is A Who Gmp Certified Exporter Of Pharmaceutical Formulations, Apis, Nutraceuticals, And Surgical Devices. It Collaborates With Accredited Factories For Manufacturing And Offers Services Like Contract Manufacturing And Product Sourcing. The Company Focuses On Global Markets Through Technical Partnerships And Aims To Enhance Pharmaceutical Supply Chains.
Amegh Pharma's top competitors include Entero Healthcare, AmerisourceBergen and Keimed.
Amegh Pharma offers Pharmaceutical Formulations, Pharmaceutical APIs, Nutraceuticals and Herbals, and Surgicals.
Amegh Pharma operates through Amegh Pharma Private Limited.
The legal entities of Amegh Pharma currently have 2 directors, including Payal Mohan, Vipul Mohan.